Royalties & Revenue Sharing

A Sustainable Model for Shared Success

Elixira is licensed through a royalty-based model that ensures long-term value creation for all partners.
Instead of a one-time transaction, licensing is structured to foster ongoing collaboration
—aligning incentives across scientific, ethical, and economic dimensions.

Royalties are based on clearly defined metrics such as market, application, and distribution volume.
This creates a transparent framework where each party benefits in proportion to real-world impact and adoption.
Optional models for tiered royalties or performance-based incentives are available based on region, scalability, and strategic alignment.

Revenue sharing is designed not only to reward innovation, but to fuel further development, access expansion, and ethical deployment. This structure supports both commercial success and societal benefit—without undermining existing healthcare systems or stakeholders.

Licensing Elixira is not just a financial agreement.
It is a commitment to shaping the future of medicine in a way that is profitable, preventive, and profoundly human.